文献速递眼底病与葡萄膜炎

NR4A1通过抑制巨噬细胞向肌成纤维细胞转化减轻视网膜下纤维化

NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究探讨NR4A1在新生血管性年龄相关性黄斑变性(nAMD)相关视网膜下纤维化(SF)中的作用;小鼠RPE-脉络膜-巩膜铺片显示巨噬细胞早期快速招募、第2周后逐渐减少,MMT于第3周达最大量;NR4A1激动剂Csn-B通过抑制AKT诱导的NR4A1磷酸化抑制MMT并减轻SF。

要点

  • 小鼠铺片显示巨噬细胞早期快速招募、第2周后逐渐减少,MMT细胞第3周达最大量。
  • 敲低NR4A1促进MMT和细胞外基质表达,Csn-B处理则产生抑制效果。
  • Csn-B抑制MMT细胞中P-NR4A1表达,MK-2206抑制持续TGF-β1诱导的NR4A1磷酸化及ECM表达。

核心结论

  • NR4A1抑制视网膜下纤维化中的MMT并减少细胞外基质沉积。
  • 其激动剂Csn-B通过抑制AKT诱导的NR4A1磷酸化来抑制MMT,从而减轻视网膜下纤维化。

研究设计与样本

  • 研究采用小鼠RPE-脉络膜-巩膜铺片连续观察巨噬细胞浸润及巨噬细胞向肌成纤维细胞转化(MMT)的变化。
  • 在TGF-β1诱导的THP-1细胞中进一步观察MMT细胞形态及细胞外基质表达差异。
  • 观察到NR4A1变化后,用小干扰RNA(siRNA)确认NR4A1在MMT中的作用。
  • 用Csn-B干预并观察MMT和视网膜下纤维化变化,以确定NR4A1是否可作为治疗靶点。

主要发现

  • 巨噬细胞在早期被快速招募,第2周后逐渐减少。
  • 病变中观察到MMT,MMT细胞数量在第3周达到最大。
  • NR4A1随诱导短暂上调,随后逐渐下降并持续磷酸化。
  • 敲低NR4A1促进MMT和细胞外基质表达,而Csn-B处理具有抑制作用。
  • Csn-B处理的MMT细胞中P-NR4A1表达显著受抑制,MK-2206抑制持续TGF-β1诱导的NR4A1磷酸化及细胞外基质表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Subretinal fibrosis (SF) secondary to neovascular age-related macular degeneration (nAMD) is the most predominant cause of central visual impairment in all patients with AMD. NR4A1 is a member of the nuclear orphan receptor superfamily, and has shown inhibitory effects on fibrosis in tissues such as the dermis, intestines, and heart. Cytosporone B (Csn-B) is a natural agonist of NR4A1. This study aims to explore whether NR4A1 plays a role in SF associated with nAMD. METHODS: Mice RPE-choroid-sclera flat mounts were prepared for serial observation of changes in macrophage infiltration, as well as macrophage to myofibroblast transformation (MMT). The morphology of MMT cells and differences in extracellular matrix (ECM) expression were further observed in TGF-β1-induced THP-1 cells. The role of NR4A1 in MMT was confirmed by small interfering RNA (siRNA) after changes in NR4A1 were observed. To determine whether NR4A1 could be a target for SF treatment, we intervened with the Csn-B and observed the MMT and SF changes. RESULTS: Macrophages were rapidly recruited in the early stage and gradually decreased after the second week. MMT was observed in the lesions and the maximum number of MMT cells was observed at the third week. NR4A1 was transiently upregulated with induction, followed by a gradual decrease and a continuous phosphorylation. The knockdown of NR4A1 promoted MMT and ECM expression, whereas treatment with Csn-B had an inhibitory effect. P-NR4A1 expression was significantly suppressed in Csn-B-treated MMT cells. Finally, MK-2206 was found to inhibit sustained TGF-β1-induced NR4A1 phosphorylation and also ECM expression. CONCLUSIONS: NR4A1 inhibits MMT and reduces ECM deposition in SF. Its agonist Csn-B inhibits MMT by inhibiting AKT-induced NR4A1 phosphorylation, which then attenuates SF.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Yang R, Zong T, Wang N, et al. NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition. Invest Ophthalmol Vis Sci. 2025. PMID: 40521981. doi:10.1167/iovs.66.6.47

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。